BRUCE KATSURA: Open Payments
NPI 1497857189 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 38 payments from 5 companies in 2025. Trend: 2023 $104 · 2024 $523 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 29 | $589 |
| Lilly USA, LLC | 6 | $226 |
| Dexcom, Inc. | 1 | $150 |
| ABBVIE INC. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Ozempic, Wegovy, Rybelsus, Dexcom G6 Transmitter, ZEPBOUND, MOUNJARO, BOTOX, FARXIGA.
Industry payments across HI — which companies pay providers there.
